-
Signature
-
/s/ Brendan Mulligan, Attorney-in-Fact
-
Issuer symbol
-
FIG
-
Transactions as of
-
10 Nov 2025
-
Net transactions value
-
-$1,300,391
-
Form type
-
4
-
Filing time
-
13 Nov 2025, 20:53:23 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Herb Tyler |
Chief Accounting Officer |
C/O FIGMA, INC., 760 MARKET STREET, FLOOR 10, SAN FRANCISCO |
/s/ Brendan Mulligan, Attorney-in-Fact |
13 Nov 2025 |
0002073587 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
FIG |
Class A Common Stock |
Options Exercise |
$604,386 |
+26,059 |
+12% |
$23.19 |
252,146 |
10 Nov 2025 |
Direct |
|
| transaction |
FIG |
Class A Common Stock |
Sale |
$540,373 |
-12,577 |
-5% |
$42.97 |
239,569 |
10 Nov 2025 |
Direct |
F1, F2 |
| transaction |
FIG |
Class A Common Stock |
Sale |
$520,074 |
-11,887 |
-5% |
$43.75 |
227,682 |
10 Nov 2025 |
Direct |
F1, F3 |
| transaction |
FIG |
Class A Common Stock |
Sale |
$844,330 |
-18,893 |
-8.3% |
$44.69 |
208,789 |
10 Nov 2025 |
Direct |
F1, F4 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
FIG |
Stock Option (Right to Buy) |
Options Exercise |
$0 |
-26,059 |
-86% |
$0.000000 |
4,311 |
10 Nov 2025 |
Class A Common Stock |
26,059 |
$23.19 |
Direct |
F5, F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: